ArticlePharmacoEconomics2009

Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications.

Shien Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.